天然产物 糖类和糖苷 Saccharides and Glycosides
Rhodiosin (Synonyms: 红景天素) 纯度: 99.07%
Rhodiosin 是从红景天 (Rhodiola crenulata) 的根中分离的,一种特异性非竞争性细胞色素 P450 2D6 抑制剂,IC50 为 0.420 μM,Ki 为 0.535 μM。Rhodiosin 有效的,剂量依赖性抑制乙酰胆碱酯酶 (AChE),IC50 范围为 57.50 至 2.43 μg/mL。Rhodiosin 具有有效的 DPPH 自由基清除活性,IC50 为 27.77 μM。

Rhodiosin Chemical Structure
CAS No. : 86831-54-1
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in DMSO | ¥2659 | In-stock | |
5 mg | ¥1980 | In-stock | |
10 mg | ¥3360 | In-stock | |
20 mg | ¥5710 | 询价 | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
Rhodiosin 相关产品
•相关化合物库:
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Neuronal Signaling Compound Library
- Natural Product Library
- Glycoside Compound Library
- Phenols Library
- Traditional Chinese Medicine Monomer Library
- Anti-Alzheimer’s Disease Compound Library
- Neurodegenerative Disease-related Compound Library
生物活性 |
Rhodiosin, isolated from the root of Rhodiola crenulata, is a specific non-competitive cytochrome P450 2D6 inhibitor with an IC50 of 0.420 μM and a Ki of 0.535 μM[1]. Rhodiosin exhibits potent, dose-dependent inhibitory effects on acetylcholinesterase (AChE) with IC50 ranged from 57.50 to 2.43 μg/mL[2]. Rhodiosin exhibits potent DPPH free radical scavenging activities, with an IC50 of 27.77 μM[3]. |
IC50 & Target |
IC50: 0.420 μM (cytochrome P450 2D6)[1];57.50-2.43 μg/mL (AChE)[2];27.77 μM (DPPH free radical scavenging)[3] |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
分子量 |
610.52 |
||||||||||||||||
Formula |
C27H30O16 |
||||||||||||||||
CAS 号 |
86831-54-1 |
||||||||||||||||
中文名称 |
红景天素 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 33.33 mg/mL (54.59 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|